Fencare Pharmaceuticals Private Limited

Fencare Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24100KA2016PTC087171 Incorporated 23 March 2016 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹17.71 Lakh
▼ 74% YoY
Net loss · FY 2025
₹8.71 Lakh
Net margin -49.2%
EBITDA · FY 2025
-₹7.61 Lakh
EBITDA margin -42.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Employees · EPFO
3
Provident fund records
Directors on board
3
As per MCA filings

About Fencare Pharmaceuticals Private Limited

Data last updated:

Fencare Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 March 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2016PTC087171. Its GSTIN is 32AACCF7917Q1Z7 (Kerala).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nimesh Elayidath (Managing Director) and Jayasankar Panichelparambil Gopalakrishnakurup.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.751 8th Cross 4th Main M C Layout Vijaynagar, Bangalore, Karnataka, India – 560040.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.71 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹8.71 Lakh (net margin -49.2%) and EBITDA of -₹7.61 Lakh (EBITDA margin -42.9%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years and 3% over five years.

The company has about 3 employees on its provident fund (EPFO) records.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100KA2016PTC087171
Registration Number 087171
Incorporation Date 23 March 2016
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Fencare Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No.751 8th Cross 4th Main M C Layout Vijaynagar, Bangalore, Karnataka, India – 560040
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Fencare Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Fencare Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Fencare Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Fencare Pharmaceuticals Private Limited, buy the company report.

Financials of Fencare Pharmaceuticals Private Limited

FY 2025 filings available

Fencare Pharmaceuticals Private Limited reported revenue of ₹17.71 Lakh (down 74% YoY) for FY 2025.

Revenue · FY 2025
₹17.71 Lakh ▼ 74%
Net loss · FY 2025
₹8.71 Lakh margin -49.2%
EBITDA · FY 2025
-₹7.61 Lakh margin -42.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 74%
3 years · compounded
▼ 42%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 120%
3 years · compounded
▼ 90%
5 years · compounded
▼ 91%

Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 74% fall in the latest year. EBITDA fell 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹7.61 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹8.71 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-42.9%
Net Profit Margin-49.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Fencare Pharmaceuticals Private Limited, buy the company report.

Board of directors of Fencare Pharmaceuticals Private Limited

Fencare Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jayasankar Panichelparambil GopalakrishnakurupDirector23 Mar 201610 Years 7 MonthsCurrent
Sugunanambiar BijoyDirector23 Mar 201610 Years 7 MonthsCurrent
Nimesh ElayidathManaging Director23 Mar 201610 Years 7 MonthsCurrent

Auditor

Fencare Pharmaceuticals Private Limited is audited by BALAN & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
BALAN & COFY 2022000340S

Shareholding

The shareholding of Fencare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Fencare Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Fencare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Fencare Pharmaceuticals Private Limited has a workforce of 3 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
3
Active EPFO establishments
1

GST

Fencare Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
32AACCF7917Q1Z7KeralaActive01 Jul 2017

To see the full GST registrations and return filing status of Fencare Pharmaceuticals Private Limited, buy the company report.

Recent activity

Fencare Pharmaceuticals Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Avaroth Padmaprasad ceased to be Director on 05 Apr 2022.

AGM
Fencare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Fencare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Avaroth Padmaprasad ceased to be Director.
Ceased
Shibu Sekharan Nair ceased to be Director.
Appointed
Appointed
Nimesh Elayidath was appointed as Managing Director.
Appointed
Sugunanambiar Bijoy was appointed as Director.
Incorporation
23 Mar 2016
Fencare Pharmaceuticals Private Limited was registered on 23 Mar 2016 with Roc Bangalore & aged 10 years 7 months as per MCA records.

Frequently asked questions

Fencare Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 March 2016 (10+ years old) and is registered under CIN U24100KA2016PTC087171.

Fencare Pharmaceuticals has 3 current directors:

The latest financial statements of Fencare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.

The GSTIN of Fencare Pharmaceuticals is 32AACCF7917Q1Z7, registered in Kerala.

The CIN (Corporate Identification Number) of Fencare Pharmaceuticals is U24100KA2016PTC087171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Fencare Pharmaceuticals was incorporated on 23 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.

Avaroth Padmaprasad ceased to be Director on 05 Apr 2022. Shibu Sekharan Nair ceased to be Director on 27 Aug 2019. Jayasankar Panichelparambil Gopalakrishnakurup was appointed as Director on 23 Mar 2016. Fencare Pharmaceuticals has 5 board changes on record in total.

The registered office of Fencare Pharmaceuticals is at No.751 8th Cross 4th Main M C Layout Vijaynagar, Bangalore, Karnataka, India – 560040.

Fencare Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Fencare Pharmaceuticals is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.